ICB BIOTECHNOLOGY
TASE
IL Flag
ICB

ICB
ICB BIOTECHNOLOGY
IL Flag
TASE
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

ICB Stock Chart

Data for TASE is only available to registered users

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Employees: 8
Icb Biotechnology Investments Ltd, formerly BSP Biological Signal Processing Ltd, is an Israel-based company engaged in the technology sector. The Company offers products for non-invasive diagnosis and monitoring of Coronary Artery Disease (CAD). The Company’s products include: the HyperQ EX-300, a 12-lead stress Electrocardiography (ECG) system with the capability to analyze high frequency components of the ECG signal (HyperQ analysis); the HyperQ AD-100, which is a system that integrates with conventional stress ECG machines and provides HyperQ CAD analysis and the HyperQ AN-S OEM product which enables any ECG data acquisition system to enhance its diagnostic capabilities by incorporating HyperQ analysis. HyperQ technology uses a multifaceted process to interpret the information acquired by the ECG hardware. This process includes identification of the QRS complex, rejection of corrupted signals, several alignment procedures, signal to noise enhancement, and filtering.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Get Help Ideas Published Followers Following Private Messages Chat Sign Out